Clinical Research

Clinical analysis of pulmonary tuberculosis complicated with Nocardia farcinica

  • Yigang TAN ,
  • Honglan ZHONG ,
  • Chunming LUO ,
  • Xingshan CAI ,
  • Bitong WU ,
  • Hui FAN ,
  • Min. SONG
Expand
  • Guangzhou Chest Hospital,Guangzhou Key Laboratory of Tuberculosis Research,Guangzhou 510095,China

Received date: 2024-01-29

  Online published: 2024-07-15

Abstract

Objective To analyze the clinical characteristics of pulmonary tuberculosis patients complicated with infection of Nocardia farcinica aiming to improve the diagnosis and treatment the disease. Methods The clinical data of 22 cases of pulmonary tuberculosis complicated with Nocardia farcinica infection admitted to Guangzhou Chest Hospital from June 2020 to December 2023 were collected and the clinical manifestations, imaging, laboratory tests, treatment process, and disease outcomes were retrospectively analyzed. Results Among the 22 patients, there were 13 males and 9 females, aged 20 ~ 86 years, with a median age of 52 years. Common clinical manifestations included cough (22/22), sputum (21/22), and underlying diseases (13/22). One case was positive for cerebrospinal fluid culture, and 21 cases were positive for sputum culture. The culture period was 5 ~ 26 days, with a median culture period of 18 days. The imaging manifestations were mainly plaques, plaques and cavities, and the lesions were spread in both lungs (17/22) and cavities (11/22). After anti?tuberculosis treatment, the absorption of lung lesions in some patients was poor, and the absorption of the lesions was improved after anti?nocardia treatment. 8 cases were cured, 13 cases were improved and 1 case died. Conclusion The clinical symptoms of patients with pulmonary tuberculosis complicated with Nocardia farcinica were atypical, the culture period of Nocardia was long, and the imaging manifestations were similar to pulmonary tuberculosis, which is prone to misdiagnosis and missed diagnosis. For patients with poor response to anti?tuberculosis treatment and slow lesion absorption, the possibility of a concurrent Nocardia infection should be considered.

Cite this article

Yigang TAN , Honglan ZHONG , Chunming LUO , Xingshan CAI , Bitong WU , Hui FAN , Min. SONG . Clinical analysis of pulmonary tuberculosis complicated with Nocardia farcinica[J]. The Journal of Practical Medicine, 2024 , 40(14) : 1969 -1974 . DOI: 10.3969/j.issn.1006-5725.2024.14.012

References

1 HUANG L, SUN L Y, YAN Y. Characteristics of nocardiosis patients with different immune status from a Chinese tertiary general hospital during 8-year period A STROBE-compliment observational study[J]. Medicine (Baltimore), 2019,98(45): e17913. doi:10.1097/md.0000000000017913
2 YADAV P, KUMAR D, MEENA D S,et al. Clinical Features, Radiological Findings, and Treatment Outcomes in Patients with Pulmonary Nocardiosis: A Retrospective Analysis[J]. Cureus,2021,13(8): e17250. doi:10.7759/CUREUS.17250
3 ZHONG C, HUANG P P, ZHAN Y S,et al. Clinical Features of Pulmonary Nocardiosis in Patients with Different Underlying Diseases:A Case Series Study[J]. Infect Drug Resist, 2022,15:1167-1174. doi:10.2147/idr.s359596
4 WEI M, XU X M, YANG J X,et al. MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates:a multicenter retrospective study in China[J]. BMC Microbiol, 2021,21(1):342. doi:10.1186/s12866-021-02412-x
5 中国结核病预防控制工作技术规范( 2020 版)诊断标准。
6 中华人民共和国卫生行业标准W S288-2017结核病诊断标准。
7 阮继生. “伯杰氏系统细菌学手册(第二版)”第5卷与我国的放线菌系统学研究 [J]. 微生物学报, 2013, 53(6): 521-530.
8 BARBARA A B, JUNE M B, PATRICIA S C, et al. Clinical and laboratory features of the Nocardia spp.based on current molecular Taxonomy[J]. Clin Microbiol Rev, 2006,19(2):259-282. doi:10.1128/cmr.19.2.259-282.2006
9 WANG C H, SUN Q, YAN J,et al. The species distribution and antimicrobial resistance profiles of Nocardia species in China: A systematic review and meta-analysis[J]. PLoS Negl Trop Dis,2023,17(7):e0011432. doi:10.1371/journal.pntd.0011432
10 BAI Y H, LIU K Y, CHEN Y Q,et al. Disseminated Infection of Nocardia farcinica in an Immunocompetent Adult: Mistaken for Tuberculosis Bacilli in Acid-Fast Staining of Bronchoalveolar Lavage Fluid[J]. J Cytol, 2021,38(2):106-108. doi:10.4103/joc.joc_208_20
11 ENGELBRECHT A, SAAD H, GROSS H,et al. Natural?Products from Nocardia and Their?Role?in?Pathogenicity[J]. Microb Physiol, 2021,31(3): 217-232. doi:10.1159/000516864
12 MURICY E C, LEMES R A, BOMBARDA S,et al. Differentiation between Nocardia spp. and Mycobacterium spp.: Critical aspects for bacteriological diagnosis[J]. Rev Inst Med Trop Sao Paulo,2014,56(5):397-401. doi:10.1590/s0036-46652014000500005
13 DUGGAL S D, CHUGH T D. Nocardiosis: A?Neglected?Disease.Med Princ Pract[J]. Med Princ Pract, 2020,29(6):514-523. doi:10.1159/000508717
14 HU Y N, ZHU Y, LI C,et al. Evaluation of BACTEC MGIT 960 system for recovery of Nocardia from clinical specimens[J]. Diagn Microbiol Infect Dis, 2023,106(4):115989. doi:10.1016/j.diagmicrobio.2023.115989
15 牟向东,郭文佳,蔡存良,等. 支气管扩张症合并肺诺卡菌病临床病例分析[J]. 中华结核和呼吸杂志, 2022,3(45):276-281. doi:10.3760/cma.j.cn112147-20211128-00844
16 STEINBRINK J, LEAVENSL J, KAUFFMAN C A,et al. Manifestations and outcomes of nocardia infections Comparison of immunocompromised and nonimmunocompromised adult patients[J].Medicine (Baltimore), 2018,97(40):e12436. doi:10.1097/md.0000000000012436
17 JIAO M F, MA X X, LI Y G,et al. Metagenomic next-generation sequencing provides prognostic warning by identifying mixed infections in nocardiosis[J]. Front Cell Infect Microbiol, 2022,12:894678. doi:10.3389/fcimb.2022.894678
18 WANG L, XU Y, CHEN Z,et al. Nocardiosis: A two-center analysis of clinical characteristics[J]. Front Med(Lausanne), 2022,9: 996442. doi:10.3389/fmed.2022.996442
19 YETMAR Z A, KHODADADI R B, CHESDACHAI S,et al. Mortality After Nocardiosis: Risk Factors and Evaluation of Disseminated Infection[J]. Open Forum Infect Dis, 2023,10(8):ofad409. doi:10.1093/ofid/ofad409
20 练巧燕,陈奥,徐鑫,等. 肺移植受者诺卡菌感染5例临床分析[J]. 中华器官移植杂志, 2021,42(7),417-421. doi:10.3760/cma.j.cn421203-20200303-00055
21 李君,陈虹,吴广东,等. 肝移植术后皮疽诺卡菌感染1例[J].中华器官移植杂志, 2022,43(10):622-624.
22 AKANE T, TAKASHI Y, YASUAKI T,et al. Nocardiosis in Japan:a Multicentric Retrospective Cohort Study[J]. Antimicrob Agents Chemother, 2022,66(2):e0189021. doi:10.1128/aac.01890-21
23 KHURRAM Z, TAHA N, MUHAMMAD F,et al. Ten Year Review of Pulmonary Nocardiosis: A Series of 55 Cases[J]. Cureus,2019,11(5): e4759.
24 RUBEN M B. Isolated Nocardiosis, an Unrecognized Primary Immunodeficiency?[J]. Front Immunol, 2020,11:590239. doi:10.3389/fimmu.2020.590239
25 DONG G W, CHU P, GUO J,et al. Nontuberculous mycobacterial and Nocardia infections mimicking pulmonary tuberculosis: a retrospective study of a general hospital patient population in China[J]. J Med Microbiol, 2020,69(9):1145-1150. doi:10.1099/jmm.0.000961
26 MEHRABADI S M, TARAGHIAN M, PIROUZI A,et al. Pulmonary Nocardiosis in Suspected Tuberculosis Patients: A Systematic Review and Meta- Analysis of Cross-Sectional Studies[J].Ethiop J Health Sci, 2020, 30(2):293-300. doi:10.4314/ejhs.v30i2.17
27 ALIZADEH S A, JAVADI A, MARDANEH J,et al. Development of a SYBR Green Multiplex Real Time PCR for Simultaneous Detection of Mycobacterium Tuberculosis and Nocardia Asteroides in Respiratory Samples[J]. Ethiop J Health Sci, 2021,31(2):241-246. doi:10.4314/ejhs.v31i2.6
28 UMAIRI R S, PANDAK N, BUSAIDI M A. The Findings of Pulmonary Nocardiosis on Chest High Resolution Computed Tomography:Single centre experience and review of literature[J]. Sultan Qaboos Univ Med J, 2022,22(3):357-361. doi:10.18295/squmj.9.2021.131
29 叶涛,杨杰,傅昌瑜,等. 肺诺卡菌病的胸部CT特征[J]. 国际呼吸杂志, 2020, 40(24):1862-1867. doi:10.3760/cma.j.cn131368-20200328-00229
30 NDLOVU M, JEENA P M, THULA S A,et al. Disseminated nocardiosis in an immunocompetent patient[J]. Afr J Thorac Crit Care Med, 2019,25(4):10.7196/AJTCCM.2019.v25i4.026. doi:10.7196/sarj.2019.v25i4.026
31 SINGH A, CHHINA D, SONI R K,et al. Clinical spectrum and outcome of pulmonary nocardiosis: 5-year experience[J]. Lung India, 2016, 33(4):398-403. doi:10.4103/0970-2113.184873
32 LI J, SHEN H, YU T,et al. Isolation and Characterization of Nocardia Species from Pulmonary Nocardiosis in a Tertiary Hospital in China[J]. Jpn J Infect Dis, 2022,75(1):31-35. doi:10.7883/yoken.jjid.2020.1096
Outlines

/